These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously? van der Meché FG Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934 [No Abstract] [Full Text] [Related]
14. [Acute demyelinating motor neuropathy: an atypical form of the Guillain-Barre syndrome?]. Corcia P; Beaume A; Guennoc AM; de Toffol B; Preud'homme JL; Autret A Rev Neurol (Paris); 1999 Sep; 155(8):596-7. PubMed ID: 10486851 [TBL] [Abstract][Full Text] [Related]
15. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination. Berciano J; Coria F; Montón F; Calleja J; Figols J; LaFarga M Muscle Nerve; 1993 Jul; 16(7):744-51. PubMed ID: 8505931 [TBL] [Abstract][Full Text] [Related]
17. Second response to immunoglobulin in recurrent Guillain-Barré syndrome. Nagappan R; Barker J N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925 [TBL] [Abstract][Full Text] [Related]
19. [Guillain-Barré disease: a current treatment method using immunoglobulins]. Kleyweg RP; van der Meché FG Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903 [No Abstract] [Full Text] [Related]
20. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]